188 related articles for article (PubMed ID: 16900662)
1. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management.
Bongiovanni M; Tincati C
Curr Mol Med; 2006 Jun; 6(4):395-400. PubMed ID: 16900662
[TBL] [Abstract][Full Text] [Related]
2. Bone disorders associated with the human immunodeficiency virus: pathogenesis and management.
Qaqish RB; Sims KA
Pharmacotherapy; 2004 Oct; 24(10):1331-46. PubMed ID: 15628831
[TBL] [Abstract][Full Text] [Related]
3. Bone disorders in human immunodeficiency virus infection.
Glesby MJ
Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
5. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
Clay PG; Voss LE; Williams C; Daume EC
Ann Pharmacother; 2008 May; 42(5):670-9. PubMed ID: 18413693
[TBL] [Abstract][Full Text] [Related]
6. Emerging bone problems in patients infected with human immunodeficiency virus.
Mondy K; Tebas P
Clin Infect Dis; 2003 Apr; 36(Suppl 2):S101-5. PubMed ID: 12652379
[TBL] [Abstract][Full Text] [Related]
7. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
Escota GV; Mondy K; Bush T; Conley L; Brooks JT; Önen N; Patel P; Kojic EM; Henry K; Hammer J; Wood KC; Lichtenstein KA; Overton ET
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):59-67. PubMed ID: 26366785
[TBL] [Abstract][Full Text] [Related]
8. [Are bones in HIV-infected patient really fragile?].
Biver E; Ciaffi L; Rizzoli R; Calmy A
Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
[TBL] [Abstract][Full Text] [Related]
9. HIV infection--a risk factor for osteoporosis.
Thomas J; Doherty SM
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):281-91. PubMed ID: 12843738
[TBL] [Abstract][Full Text] [Related]
10. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
11. Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients.
Linari S; Montorzi G; Bartolozzi D; Borderi M; Melchiorre D; Benelli M; Morfini M
Haemophilia; 2013 Jan; 19(1):126-33. PubMed ID: 22776099
[TBL] [Abstract][Full Text] [Related]
12. HIV and bone disease.
Stone B; Dockrell D; Bowman C; McCloskey E
Arch Biochem Biophys; 2010 Nov; 503(1):66-77. PubMed ID: 20682280
[TBL] [Abstract][Full Text] [Related]
13. Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis.
Guaraldi G; Orlando G; Madeddu G; Vescini F; Ventura P; Campostrini S; Mura MS; Parise N; Caudarella R; Esposito R
HIV Clin Trials; 2004; 5(5):269-77. PubMed ID: 15562367
[TBL] [Abstract][Full Text] [Related]
14. [Osteopathies that weaken HIV-infected patients].
Rey D
Presse Med; 2003 Dec; 32(39):1857-63. PubMed ID: 14713883
[TBL] [Abstract][Full Text] [Related]
15. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
[TBL] [Abstract][Full Text] [Related]
16. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
[TBL] [Abstract][Full Text] [Related]
17. Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.
Bryant ML; Worthington MA; Parsons K
Ann Pharmacother; 2009 Apr; 43(4):714-20. PubMed ID: 19336653
[TBL] [Abstract][Full Text] [Related]
18. Interventions for the treatment of decreased bone mineral density associated with HIV infection.
Lin D; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005645. PubMed ID: 17443607
[TBL] [Abstract][Full Text] [Related]
19. Bone loss in patients with HIV infection.
Paccou J; Viget N; Legrout-Gérot I; Yazdanpanah Y; Cortet B
Joint Bone Spine; 2009 Dec; 76(6):637-41. PubMed ID: 19945322
[TBL] [Abstract][Full Text] [Related]
20. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
Pinzone MR; Moreno S; Cacopardo B; Nunnari G
AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
